Gluch, 2005 - Google Patents
Magnetic resonance in surgical oncology: II–literature reviewGluch, 2005
- Document ID
- 15778970119313637560
- Author
- Gluch L
- Publication year
- Publication venue
- ANZ journal of surgery
External Links
Snippet
Ex vivo and in vivo applications of magnetic resonance spectroscopy have been developed which aid in distinguishing malignant from normal tissues. Studies of breast, colon, cervix, oesophageal and prostate cancer reveal both the successes and failings of present …
- 210000001519 tissues 0 abstract description 32
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay
- G01N33/574—Immunoassay; Biospecific binding assay for cancer
- G01N33/57407—Specifically defined cancers
- G01N33/57434—Specifically defined cancers of prostate
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01R—MEASURING ELECTRIC VARIABLES; MEASURING MAGNETIC VARIABLES
- G01R33/00—Arrangements or instruments for measuring magnetic variables
- G01R33/20—Arrangements or instruments for measuring magnetic variables involving magnetic resonance
- G01R33/44—Arrangements or instruments for measuring magnetic variables involving magnetic resonance using nuclear magnetic resonance [NMR]
- G01R33/46—NMR spectroscopy
- G01R33/465—NMR spectroscopy applied to biological material, e.g. in vitro testing
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01R—MEASURING ELECTRIC VARIABLES; MEASURING MAGNETIC VARIABLES
- G01R33/00—Arrangements or instruments for measuring magnetic variables
- G01R33/20—Arrangements or instruments for measuring magnetic variables involving magnetic resonance
- G01R33/44—Arrangements or instruments for measuring magnetic variables involving magnetic resonance using nuclear magnetic resonance [NMR]
- G01R33/48—NMR imaging systems
- G01R33/54—Signal processing systems, e.g. using pulse sequences, Generation or control of pulse sequences ; Operator Console
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DeFeo et al. | A decade in prostate cancer: from NMR to metabolomics | |
| Gibbs et al. | Diffusion imaging of the prostate at 3.0 tesla | |
| US8404487B2 (en) | Magnetic resonance spectroscopy of breast biopsy to determine pathology, vascularization and nodal involvement | |
| Shin et al. | Prediction of pathologic response to neoadjuvant chemotherapy in patients with breast cancer using diffusion‐weighted imaging and MRS | |
| Shin et al. | Evaluation of breast cancer using proton MR spectroscopy: total choline peak integral and signal-to-noise ratio as prognostic indicators | |
| Jordan et al. | NMR-based metabolomics approach to target biomarkers for human prostate cancer | |
| Mountford et al. | Proton spectroscopy provides accurate pathology on biopsy and in vivo | |
| Liang et al. | Multiple mathematical models of diffusion-weighted magnetic resonance imaging combined with prognostic factors for assessing the response to neoadjuvant chemotherapy and radiation therapy in locally advanced rectal cancer | |
| Esseridou et al. | In vivo detection of choline in ovarian tumors using 3D magnetic resonance spectroscopy | |
| Thakur et al. | Diagnostic usefulness of water‐to‐fat ratio and choline concentration in malignant and benign breast lesions and normal breast parenchyma: an in vivo 1H MRS study | |
| Kumar et al. | Prebiopsy magnetic resonance spectroscopy and imaging in the diagnosis of prostate cancer | |
| Padhani | Integrating multiparametric prostate MRI into clinical practice | |
| Wu et al. | Metabolomic imaging for human prostate cancer detection | |
| Crisi et al. | Lipid and Macromolecules Quantitation in Differentiating Glioblastoma From Solitary Metastasis: A Short–Echo Time Single-Voxel Magnetic Resonance Spectroscopy Study at 3 T | |
| Spur et al. | Metabolomic imaging of prostate cancer with magnetic resonance spectroscopy and mass spectrometry | |
| Stijns et al. | USPIO-enhanced MRI of lymph nodes in rectal cancer: A node-to-node comparison with histopathology | |
| Mansour et al. | Proton MR spectroscopy and the detection of malignancy in ovarian masses | |
| Takeuchi et al. | Preliminary observations and clinical value of N-acetyl resonances in ovarian tumours using in-vivo proton MR spectroscopy at 3T | |
| Xiong et al. | Value of MRI texture analysis for predicting high-grade prostate cancer | |
| US20090030618A1 (en) | System, method and software arrangement for analyzing and correlating molecular profiles associated with anatomical structures | |
| Girometti et al. | Negative predictive value for cancer in patients with “Gray‐Zone” PSA level and prior negative biopsy: Preliminary results with multiparametric 3.0 tesla MR | |
| Wang et al. | [Retracted] Hydrogen Proton Magnetic Resonance Spectroscopy (MRS) in Differential Diagnosis of Intracranial Tumors: A Systematic Review | |
| Testa et al. | Accuracy of MRI/MRSI‐based transrectal ultrasound biopsy in peripheral and transition zones of the prostate gland in patients with prior negative biopsy | |
| EP1223856B1 (en) | Magnetic resonance spectroscopy of breast biopsy to determine pathology, vascularization and nodal involvement | |
| Gluch | Magnetic resonance in surgical oncology: II–literature review |